Spectral EEG analysis has been successfully utilized in previous studies on migraine patients. The aim of our study was to evaluate, by means of EEG mapping, potential correlations between the efficacy of flunarizine treatment in migraine patients and the EEG pattern recorded after chronic flunarizine therapy. Flunarizine was found to modify the non-specific EEG abnormalities of our migraine patients as well as evoke a positive clinical response.
PucaFMMinerviniMGGencoSSavareseMAntonaciFBrancasiBNapoletanoVMonettiC. EEG Spectral analysis in common and classic migraine. Cephalalgia1985;5 (Suppl 3):382.
2.
BussoneGSinatraMGBoiardiALe MantiaLFredianiFCocchiniF. Brainstem auditory evoked potentials in migraine patients in basal conditions and after chronic flunarizine treatment. Cephalalgia1985;5 (Suppl 2):177–80.
3.
Ad Hoc Committee on Classification of Headache of the NIH. JAMA1962;178:717–18.
4.
AmeryWKWauquierAVan NuetenJMDe ClerkFVan ReempstSJVJanssenPAJ. The antimigrainous pharmacology of flunarizine, a calcium antagonist. Drug Exp Clin Res1981;7:1–10.
5.
AmeryWK. Flunarizine, a calcium channel blocker, a new prophylactic drug in migraine. Headache1983;23:70–4.
6.
DiamondSSchenbaumH. Flunarizine, a calcium channel blocker, in the prophylactic treatment of migraine. Headache1983;23:39–42.
7.
CerboRCasacchiaMFormisanoRFelicianiMCusimanoGBuzziMGAgnoliA. Flunarizinepizotifen single-dose double-blind cross-over trial in migraine patients. Cephalalgia1986;6:15–18.
8.
DesmedtCKGNiemegeersCJEJanssenPAJ. Anticonvulsant properties of cinnarizine and flunarizine in rats and mice. Arzneimittelforsch1975;25:1408–13.
9.
AshtonDWauquierA. Effects of some antiepileptic, neuroleptic and gabaniergic drugs on convulsions induced in rats by injection of D,L-Allyglicine. Pharmacol Biochem Behav1979;11:221–6.
10.
OverwegJBinnieCDMeyerJWAMeinardiHNuytenSTMSchmaltzSWauquierA. Double-blind placebo-controlled trial of flunarizine as addon therapy in epilepsy. Epilepsia1984;25:217–22.
